Company news

Shanghai Zj Bio-tech Co. Ltd Class A (SSE:688317) news

Shanghai Zj Bio-tech Co. Ltd Class A news releases on 6ix. Latest, Sep 24, 2026: "Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Convening the 2026…

View Shanghai Zj Bio-tech Co. Ltd Class A →

Press releases & updates

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

September 23, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Opening a Special Account for Raised Funds and Signing the Supervision Agreement for Such Account

August 31, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

August 27, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

August 14, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026

July 29, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Relevant Certifications for the Company's Products

July 20, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Voluntary Disclosure of the Company's Products Included in the WHO Emergency Use List

July 6, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Progress of the Third Repurchase of Company Shares in 2025 through Call Auction

July 2, 2026

"Shanghai ZJ Bio-Tech Co., Ltd."Announcement on Implementing Cancellation of Repurchased Shares and Share Changes

June 30, 2026

Announcement on the 3rd Call Auction Repurchase in 2025 Reaching 2% of Total Shares, and the Progress in Share Repurchase

June 18, 2026

Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

June 8, 2026

Announcement on Voluntary Disclosure of Wholly-owned Subsidiary Certified as High-tech Enterprise

June 4, 2026

Announcement on Progress in Repurchasing Shares through Call Auction for the 3rd Time in 2025

June 2, 2026

Announcement on Voluntary Disclosure of Obtaining Certain Certification for the Company's Products

May 19, 2026

Announcement on Cancellation of Partial Repurchased Shares and Reduction of Registered Capital and Notice to Creditors

May 14, 2026

Announcement on Convening the 2025 Annual Performance Briefing

May 7, 2026

Announcement on Reversal of Asset Impairment Provision for Q1 2026

April 29, 2026

Announcement on Election of Board of Directors at Expiry of Term of Office

April 23, 2026

Announcement on Preliminary Earnings Estimate for 2025

February 27, 2026

Announcement on Estimated Daily Related Party Transactions in 2026

February 25, 2026

SHANGHAI ZJ BIO-TECH CO., LTD: Announcement on the 3rd Call Auction Repurchase in 2025 Reaching 1% of Total Shares, and the Progress in Share Repurchase

February 2, 2026

Earnings Preannouncement for 2025

January 22, 2026

Announcement on Cancellation of Some Accounts for Raised Funds

January 4, 2026

Announcement on Change of Signatory Certified Public Accountant and Project Quality Control Reviewer

December 17, 2025

Announcement on Opening a Special Account for Raised Funds and Signing a Supervision Agreement on Special Account for Raised Funds

December 9, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 24, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

November 14, 2025

Sanyou Bio and Shanghai ZJ Bio-Tech Sign Strategic Cooperation Agreement on Automated Development of Innovative Biologics to Jointly Tackle R&D Bottlenecks and Provide New Momentum for Innovative Drug R&D

November 3, 2025

Announcement on Reversal of Asset Impairment Provision for the First Three Quarters of 2025

October 29, 2025

Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase

October 23, 2025

Announcement on the 3rd Plan in 2025 for Repurchasing Shares through Call Auction

October 16, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

September 23, 2025

Announcement on Voluntary Disclosure of Company Products Being Included in the WHO Emergency Use Listing

September 18, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

September 15, 2025

Announcement on Resolutions of the 13th Meeting of the 5th Board of Supervisors

August 28, 2025

Announcement on Implementation Results of the 2nd Share Repurchase in 2025

July 28, 2025

Announcement on Progress in Repurchasing Shares through Call Auction for the Second Time in 2025

July 1, 2025

Announcement on Repurchasing 2% of the Company's Share Capital through Call Auction for the Second Time in 2025 and Repurchase Progress

June 26, 2025

Announcement on Repurchasing 1% of the Company's Share Capital through Call Auction for the Second Time in 2025 and Repurchase Progress

June 11, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 15, 2025

Announcement on the 2nd Initial Repurchase of Shares through Call Auction and Progress in Share Repurchase

May 14, 2025

Announcement on Resolution of the 14th Meeting of the 5th Board of Directors

April 29, 2025

2024 Annual Report

April 24, 2025

Announcement on Implementation Results of Share Repurchase

April 14, 2025

Announcement on Repurchasing 3% of the Company's Share Capital through Call Auction and Repurchase Progress

April 8, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

April 1, 2025

Announcement on Voluntary Disclosure of Relevant Certification for the Company's Products

March 26, 2025

Announcement on Voluntary Disclosure of Wholly-owned Subsidiary Passing High-Tech Enterprise Recertification

March 24, 2025

Announcement on Repurchasing 2% of the Company's Share Capital through Auction and Repurchase Progress

March 11, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 27, 2025

Older →